
🚨 Exciting PhD Opportunity! 🚨 Join our cutting-edge research at the University of Leicester exploring mediators of loin pain in IgA nephropathy! #IgAN @IgAN_J @haresh11 le.ac.uk/study/research-degr… @IgAN_JBarratt

Higher Specialist Nephrology Trainee | @KRUK Research Fellow (IgAN) | @GlomCon GN Fellow | python_student() | I heart glomeruli - we must save them all.

🚨 Exciting PhD Opportunity! 🚨 Join our cutting-edge research at the University of Leicester exploring mediators of loin pain in IgA nephropathy! #IgAN @IgAN_J @haresh11 le.ac.uk/study/research-degr… @IgAN_JBarratt

Massive thank you to @uniofleicester, @IgAN_JBarratt, @haresh11, Lydia and Max for all the support. Sharing knowledge and learning from the experts
The outstanding @ChloeECWil presenting exciting age-inclusive work on digital spatial profiling in IgAN/IgAVN at #ESPN2024, a @uniofleicester and @LivUni collaboration! Looking forward to the full results (especially the complement-related findings!!) @ESPNSociety @EspnYpnn

Come join us in Brighton for the autumn SpR club meeting on 14-15th October…book on before it’s too late ! eventbrite.co.uk/e/spr-club-…

We are excited to announce that the next SpR club Autumn meeting is in sunny (hopefully) Brighton. We will have some of the biggest names in research attending, a great opportunity for networking. Also fish and chips by the seaside is nice. eventbrite.co.uk/e/spr-club-…

1/ A patient receiving his first-ever dose of IV Iron (ferumoxytol) suddenly develops diffuse face & trunk flushing, chest pain, myalgias, and anxiety. Blood pressure is normal and lungs are clear. You are called to the bedside to assess. How likely is anaphylaxis?

Out today! The @KidneyBeamTrial protocol and baseline paper. A novel digital health intervention to support physical activity and self-management for ppl with CKD. Watch this space for the results- huge potential to impact care @sharleneuk @Kidney_Research bmcnephrol.biomedcentral.com…

Pneumocystis Jirovecii Pneumonia Prophylaxis by Dr. Dilushi Wijayaratne, MBBS MD (Medicine) MRCP(UK) Check it out here 👉🏻 pubs.glomcon.org/pneumocysti… #GlomCon

An estimated 850 million people worldwide suffer from chronic kidney disease, and it is expected to become the fifth leading cause of death globally by 2040. Read more about the burden of CKD worldwide here: theisn.org/initiatives/globa… #WorldKidneDay #KidneyDisease #GlobalIssue

🔴Don't miss this broadcast next week, where @ShelleyZieroth @BonanadClara @AndrewFrankel1 & @drjamesburton explore emerging data and the changing landscape of medical management of hyperkalaemia ow.ly/4os150NRo9J #CardioTwitter #MedEd

Whenever you look to generalise from a small sample watch out for sampling bias (and all other sorts of bias that can easily creep in). Extreme example from How to Lie with Statistics by Darrell Huff: amzn.to/3xZCWpo

Come work with me !
This tweet is unavailable

Not to be missed crash course for those embarking on a career as renal registrar
For those starting or soon to start renal training! Booking is now open for our 2nd renal crash course. For top tips for the first few months of the job please join us in Bristol in July. Sign up here 👇 eventbrite.co.uk/e/how-to-be… @RenalSpRClub @UKKidney

Sparsentan in patients with IgA nephropathy - treatment with sparsentan produced meaningful reduction in proteinuria compared with irbesartan in adults with IgA nephropathy. Published today. @TheLancet


#nephworking #renalsprclub #dinnertime @CaesarOlGeezer @GlomerulaRajah @Javeria_Xx @nimmikins @alannaturtles @haresh11

The temptation to use immunosuppression in crescentic IgAN is strong, but is it appropriate? Check out a case study: https://t.co/5kDm8vJNSs #IgANephropathy